Company intelligence / Profile preview

RAN Biotechnologies

Beverly, Massachusetts, United Statesranbiotechnologies.com ↗

Ownership: Private
Employees: ~16
Development stage: Commercial

Overview

RAN Biotechnologies develops and supplies advanced chemicals, micro/nanomaterials, fluorosurfactants for water-in-oil emulsions in microfluidics, functionalized hydrogel beads, affinity chromatography resins for capturing/detecting microbes/proteins. Their products enable next-generation sequencing workflows, single-cell assays, drug screening platforms and rapid detection of biologicals. They are an enabler in the life sciences research ecosystem but do not themselves conduct clinical trials or develop drugs.

Modalities: NanoparticleHydrogel-based drug delivery therapySurface coating
Industry: Chemicals & Materials

Partnerships

Member of North Shore InnoVentures incubatorMIT Venture Mentoring Service participant

Beyond the preview

Go deeper on RAN Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAN Biotechnologies.

Explore the full profile